Evidence map›Paper›PMID 35227036›Full record

ArticleTurkish journal of pharmaceutical sciences2022

Response Surface Methodology in Spectrophotometric Estimation of Saxagliptin, Derivatization with MBTH and Ninhydrin

Sunitha Gurrala, Shiva Raj, Subrahmanyam Cvs, Durga Panikumar Anumolu, Swathi Naraparaju, Harika Nizampet

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sunitha GurralaOsmania University, University College of Technology, Department of Pharmacy, Hyderabad, IndiaORCID 0000-0001-6251-2763
Shiva RajOsmania University, University College of Science, Department of Chemistry, Hyderabad, IndiaORCID 0000-0002-2870-5112
Subrahmanyam CvsOsmania University, Gokaraju Rangaraju College of Pharmacy, Hyderabad, IndiaORCID 0000-0002-5645-1922
Durga Panikumar AnumoluOsmania University, Gokaraju Rangaraju College of Pharmacy, Hyderabad, IndiaORCID 0000-0001-5010-7488
Swathi NaraparajuOsmania University, Gokaraju Rangaraju College of Pharmacy, Hyderabad, IndiaORCID 0000-0003-1442-6435
Harika NizampetOsmania University, Gokaraju Rangaraju College of Pharmacy, Hyderabad, IndiaORCID 0000-0002-3737-428X
Osmania University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Design of experiments assisted spectrophotometric methods have been established for the quantification of saxagliptin in pharmaceutical formulation Materials and Methods: Box-Behnken design was exploited in method-1, involved the measurement of absorbance of green/blue-colored complex (at 600 nm), formed by the reaction of saxagliptin with 3-methyl-2-benzothiazolinone hydrazone in the presence of ferric chloride. The central composite design was employed in method-2, involved the determination of absorbance of Ruhemann's purple (at 585 nm), formed by the reaction of the primary amine group of saxagliptin with ninhydrin reagent in presence of sodium hydroxide. Optimization of reaction variables namely, reagent concentration (A), oxidizing agent/alkalinity (B) and reaction/heat time (C) was performed through response surface methodology for the response (Y) Results: Saxagliptin executed linearity in the concentration range of 0.01-0.25 μg/mL and 1-10 μg/mL by method-1 and 2. A high value of molar absorptivity, low values of Sandell's sensitivity and limit of detection/limit of quantification divulges the good sensitivity methods. The % assay of saxagliptin in the marketed formulation was found to be 100.27 and 99.86 by method-1 and method-2, respectively. Conclusion: The proposed eco-friendly and economical methods can be routinely employed in quality control for the analysis of saxagliptin in the pharmaceutical dosage forms.

Indexed as

BBD,CCDMBTHninhydrinSaxagliptin

Identifiers

PMID35227036
PMCPMC8892554
OpenAlexW3156158642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.